NCT01534663 - Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure | Biotech Hunter

Enrollment

31

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions

Heart Failure

Interventions

DRUG

Glutamine and Fish Oil Supplementation

This is a prospective, randomized double-blind, placebo-controlled study design. 38 subjects will be randomized to two groups (19 patients in each group), one taking active fish oil and glutamine supplementation and the other taking placebo for 90 days.

DRUG

Placebo

This is a prospective, randomized double-blind, placebo-controlled study design. 38 subjects will be randomized to two groups (19 patients in each group), one taking active fish oil and glutamine supplementation and the other taking placebo for 90 days.

Trial Locations (1)

10032

Columbia University Medical Center, New York